Optimierung der Stimulationssequenz
Anmelder: St. Jude Medical AB 🇸🇪
Details
- Veröffentlichungs-Nr.
- EP2586492
- Aktenzeichen
- EP11186404
- Anmeldetag
- 24. Oktober 2011
- Veröffentlichung
- 18. Juni 2014
- Erteilung
- 18. Juni 2014
- Rechtsraum
- EP
- IPC
- A61N1/362A61N1/365
Abstract
An implantable medical device (100) is connected to a multipolar LV lead (30) and an implantable sensor (60). The sensor signal from the sensor (60) is used to identify a time point of mitral valve closure for a cardiac cycle when a ventricular pulse generator (130) generates pacing pulses that are applied to the electrodes (32, 34, 36, 38, 52, 54) of the multipolar LV lead (30) according to a pacing sequence. A time interval processor (154) determines the time interval from onset of LV activation to the time point of mitral valve closure. This procedure is repeated for multiple different pacing sequences of a sequence set. The pacing sequence that resulted in shortest time interval is then selected by a selector (156) as the currently optimal pacing sequence for the patient (10).
Anmelder
- Firma
- St. Jude Medical AB
- Land
- 🇸🇪 Schweden
St. Jude Medical, Cardiology Division, Inc. ist eine US-amerikanische Konzerneinheit für kardiologische Medizinprodukte (heute Teil von Abbott) mit Patenten zu Herzkathetern und Kardiologie-Implantaten.
1.240 Patente in unserer Datenbank